Comparative efficacy of PsyPills and OCAT mobile psychological interventions in reducing depressive, anxiety and stress symptoms: A blinded randomized clinical trial
Journal of Affective Disorders · 2025
DOI: 10.1016/j.jad.2024.10.052 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2025. Verfasst von Vasile Sîrbu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Evidence-Based Psychological Assessment and Interventions Doctoral School, Babes-Bolyai University, Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Mobile Applications, Stress, Psychological, Depression, Anxiety. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Digital applications, such as in smartphone apps format, have shown high suggestive evidence for their efficacy in reducing general distress, but rigorous studies of their efficacy in symptom change and the mechanisms involved are still needed. METHODS: In the current multi-arm parallel-group randomized trial, participants aged 18-65 with smartphone access were recruited through social media. They were randomly assigned to two app interventions (PsyPills and OCAT) or an active placebo group (shamOCAT). The primary outcome was psychological distress measured up to one month. RESULTS: A total of 229 participants from diverse regional and demographic groups of the general population of Romania were randomly allocated into the three groups (PsyPills n = 80; OCAT n = 70; shamOCAT n = 79) and included in intention-to-treat analyses. Both the PsyPills (MD = -522; 95%CI = -10.00 to -0.44; d = 0.48) and OCAT (MD = -6.30; 95%CI = -11.39 to -1.21; d = 0.58) reduced significantly, with medium effect sizes, the psychological distress levels compared with the control group at follow-up. For the separate outcomes, only PsyPills showed significant medium reduction effects for anxiety symptoms (MD = -2.17; 95%CI = -3.83 to -0.50; d = -0.60), while OCAT showed reduction effects of small size for depression (MD = -1.50 (95%CI = -3.53 to 0.54, d = -0.34), that was however statistically nonsignificant. LIMITATIONS: We registered high attrition and low adherence rates. Also, lower-than-planned effects might have been statistically underpowered to detect. CONCLUSION: The results support the high potential of both apps as scalable tools to provide low-intensity self-guided interventions for common psychological problems in the general population and expand opportunities for further research (e.g., confirm and capitulate on the differential effects).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Evidence-Based Psychological Assessment and Interventions Doctoral School, Babes-Bolyai University, Cluj-Napoca, Romania.
- DATA Lab, International Institute for Advanced Studies in Psychotherapy and Applied Mental Health, Babes-Bolyai University, Cluj-Napoca, Romania; Department of Clinical Psychology and Psychotherapy, Babes-Bolyai Univers…
- Department of Clinical Psychology, Complutense University of Madrid, 28223 Madrid, Spain.
Zitieren
APA
Sîrbu, V., David, O. A., Sanchez-Lopez, A., & Blanco, I. (2025). Comparative efficacy of PsyPills and OCAT mobile psychological interventions in reducing depressive, anxiety and stress symptoms: A blinded randomized clinical trial. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2024.10.052
Vancouver
Sîrbu V, David OA, Sanchez-Lopez A, Blanco I. Comparative efficacy of PsyPills and OCAT mobile psychological interventions in reducing depressive, anxiety and stress symptoms: A blinded randomized clinical trial. Journal of Affective Disorders. 2025. doi:10.1016/j.jad.2024.10.052
BibTeX
@article{Srbu2025,
author = {Sîrbu, Vasile and David, Oana Alexandra and Sanchez-Lopez, Alvaro and Blanco, Ivan},
title = {Comparative efficacy of PsyPills and OCAT mobile psychological interventions in reducing depressive, anxiety and stress symptoms: A blinded randomized clinical trial},
journal = {Journal of Affective Disorders},
year = {2025},
doi = {10.1016/j.jad.2024.10.052}
}
EUVIMED